Tafamidis: a review of its use in familial amyloid polyneuropathy.
about
Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart FailureNeuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathyEarly intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathyNovel pharmacotherapies for cardiac amyloidosis.Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease.Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial.Small molecules as therapeutic agents for inborn errors of metabolism.Genetic, hematological, and immunological disorders transmissible with liver transplantation.Stilbene Boronic Acids Form a Covalent Bond with Human Transthyretin and Inhibit Its Aggregation.Pharmacokinetics of tafamidis, a transthyretin amyloidosis drug, in rats.A novel transthyretin variant V28S (p.V48S) with a double-nucleotide substitution in the same codon.
P2860
Q26776120-CB18BE94-342D-466F-8D91-A8CCCBD7E0FBQ26801349-66D360C3-3E0F-4A6D-A6C7-364DAB4F61A0Q36686430-7122654F-BA82-4651-A9DD-2C99ADB59776Q36845920-B1D69E6C-6238-4242-87F9-F5F8A7637971Q37420577-82250DC5-8C36-45C9-9686-42604F776106Q37713229-FEC21D4D-CEF0-4655-BBBE-97A7117178A4Q38709793-DCFEE2F5-5400-4E58-8A2C-339F55570293Q38745211-73EDAB32-E889-487F-9512-64FF6ED52281Q38844927-E75936CB-BB32-4AED-9875-6E37E5D6899DQ39038060-23D530C5-92A8-4EAF-88B8-1D2A25F8D7E8Q39152643-CF999BD6-2413-4623-8E21-A29DD0678112Q42613719-1B7D286F-8E9E-4FD5-B68D-7FB05263CE9DQ47959196-0D2CF38D-C9B9-4940-8C4B-9EF285CAC01AQ49830721-C2BEB267-BC19-47A4-9DD4-D98770AD47F8
P2860
Tafamidis: a review of its use in familial amyloid polyneuropathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tafamidis: a review of its use in familial amyloid polyneuropathy.
@en
type
label
Tafamidis: a review of its use in familial amyloid polyneuropathy.
@en
prefLabel
Tafamidis: a review of its use in familial amyloid polyneuropathy.
@en
P2860
P1433
P1476
Tafamidis: a review of its use in familial amyloid polyneuropathy.
@en
P2860
P2888
P304
P356
10.1007/S40265-014-0260-2
P577
2014-08-01T00:00:00Z
P5875
P6179
1026806203